CDK18 and CCND1 mRNAs were less abundant in the plasma of ccRCC patients (2.1 fold change, p = 0.001 and 1.55 fold change, p = 0.039, respectively). This evidence concerns the gene CDK18 and nonpapillary renal cell carcinoma.